SH2B1β (SH2-Bβ) enhances expression of a subset of nerve growth factor-regulated genes important for neuronal differentiation including genes encoding urokinase plasminogen activator receptor and matrix metalloproteinase 3/10

Molecular Endocrinology

Volumn 22, Issue 2, 2008, Pages 454-476

  Chen, Linyi ^a,c   Maures, Travis J ^a   Jin, Hui ^a   Huo, Jeffrey S ^a   Rabbani, Shafaat A ^b   Schwartz, Jessica ^a   Carter Su, Christin ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIGEL; NERVE GROWTH FACTOR; PROTEIN SH2; PROTEIN SH2B1BETA; STROMELYSIN; STROMELYSIN 2; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; CARRIER PROTEIN; CELL SURFACE RECEPTOR; SH2BPSM1 PROTEIN, RAT; UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTORS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTORS;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL STRAIN; CYTOLOGY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; IMMUNOBLOTTING; METABOLISM; NERVE CELL; NEURITE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 3; MODELS, BIOLOGICAL; NERVE GROWTH FACTORS; NEURITES; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PC12 CELLS; RATS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 38749109194     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0384     Document Type: Article

References (94)

1. Thoenen H, Barde YA 1980 Physiology of nerve growth factor. Physiol Rev 60:1284-1335
2. Levi-Montalcini R 1987 The nerve growth factor 35 years later. Science 237:1154-1162
3. Oppenheim RW 1991 Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501
4. Sofroniew MV, Howe CL, Mobley WC 2001 Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217-1281
5. Francis NJ, Landis SC 1999 Cellular and molecular determinants of sympathetic neuron development. Annu Rev Neurosci 22:541-566
6. Oltvai ZN, Milliman CL, Korsmeyer SJ 1993 Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619
7. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, MacMahon SB, Shelton DL, Levinson AD 1994 Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001-1011
8. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M 1994 Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368:246-249
9. Patel TD, Jackman A, Rice FL, Kucera J, Snider WD 2000 Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron 25:345-357
10. Glebova NO, Ginty DD 2004 Heterogeneous requirement of NGF for sympathetic target innervation in vivo. J Neurosci 24:743-751
11. Kuruvilla R, Zweifel LS, Glebova NO, Lonze BE, Valdez G, Ye H, Ginty DD 2004 A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Cell 118:243-255
12. Greene LA, Tischler AS 1976 Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428
13. Tischler AS, Greene LA 1980 Phenotypic plasticity of pheochromocytoma and normal adrenal medullary cells. Adv Biochem Psychopharmacol 25:61-68
14. Zhou T, Xu B, Que H, Lin Q, Lv S, Liu S 2006 Neurons derived from PC12 cells have the potential to develop synapses with primary neurons from rat cortex. Acta Neurobiol Exp (Wars) 66:105-112
15. Vaudry D, Stork PJ, Lazarovici P, Eiden LE 2002 Signaling pathways for PC12 cell differentiation: making the right connections. Science 296:1648-1649
16. Schlessinger J, Ullrich A 1992 Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391
17. Choi DY, Toledo-Aral JJ, Segal R, Halegoua S 2001 Sustained signaling by phospholipase C-γ mediates nerve growth factor-triggered gene expression. Mol Cell Biol 21:2695-2705
18. Huang EJ, Reichardt LF 2003 Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642
19. Meakin SO 2000 Nerve growth factor receptors and mechanisms of intracellular signal transduction. Recent Res Dev Neurochem 3:75-91
20. Qian X, Riccio A, Zhang Y, Ginty DD 1998 Identification and characterization of novel substrates of Trk receptors in developing neurons. Neuron 21:1017-1029
21. Rui L, Herrington J, Carter-Su C 1999 SH2-B is required for nerve growth factor-induced neuronal differentiation. J Biol Chem 274:10590-10594
22. Rui L, Herrington J, Carter-Su C 1999 SH2-B, a membrane-associated adapter, is phosphorylated on multiple serines/threonines in response to nerve growth factor by kinases within the MEK/ERK cascade. J Biol Chem 274:26485-26492
23. Osborne MA, Dalton S, Kochan JP 1995 The yeast tribrid system: genetic detection of trans-phosphorylated ITAM-SH2-interactions. Biotechnology 13:1474-1478
24. Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A, Yoshimura A 1997 Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene 15:7-15
25. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI 1995 Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase Cγ1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 92:11618-11622
26. Maures TJ, Kurzer JH, Carter-Su C 2007 SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other. Trends Endocrinol Metab 18:38-45
27. Nelms K, O'Neill TJ, Li S, Hubbard SR, Gustafson TA, Paul WE 1999 Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. Mammalian Genome 10:1160-1167
28. Yousaf N, Deng Y, Kang Y, Riedel H 2001 Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis. J Biol Chem 276:40940-40948
29. Qian X, Ginty DD 2001 SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol Cell Biol 21:1613-1620
30. Chen L, Carter-Su C 2004 Adapter protein SH2-Bβ undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation. Mol Cell Biol 24:3633-3647
31. Dennis Jr. G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA 2003 DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4:P3
32. Sternlicht MD, Werb Z 2001 How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516
33. Farias-Eisner R, Vician L, Silver A, Reddy S, Rabbani SA, Herschman HR 2000 The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation. J Neurosci 20:230-239
34. Farias-Eisner R, Vician L, Reddy S, Basconcillo R, Rabbani SA, Wu YY, Bradshaw RA, Herschman HR 2001 Expression of the urokinase plasminogen activator receptor is transiently required during "priming" of PC12 cells in nerve growth factor-directed cellular differentiation. J Neurosci Res 63:341-346
35. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, Kondo T 2003 Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278:50226-50233
36. Nordstrom LA, Lochner J, Yeung W, Ciment G 1995 The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae. Mol Cell Neurosci 6:56-68
37. Popanda O, Flohr C, Dai JC, Hunzicker A, Thielmann HW 2001 A mutation in subunit B of the DNA polymerase α-primase complex from Novikoff hepatoma cells concomitant with a conformational change and abnormal catalytic properties of the DNA polymerase α-primase complex. Mol Carcinog 31:171-183
38. Basbaum CB, Werb Z 1996 Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 8:731-738
39. Ossowski L, Aguirre-Ghiso JA 2000 Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 12:613-620
40. Powell K 2003 Signalling: from the outside in. In: Signalling scissors: new perspectives on proteases. Palazzo Arzaga, Italy: Nature Publishing Group; 1-3
41. Galazka G, Windsor LJ, Birkedal-Hansen H, Engler JA 1996 APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide. Biochem 35:11221-11227
42. Angelastro JM, Klimaschewski L, Tang S, Vitolo OV, Weissman TA, Donlin LT, Shelanski ML, Greene LA 2000 Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling. Proc Natl Acad Sci USA 97:10424-10429
43. Oe T, Sasayama T, Nagashima T, Muramoto M, Yamazaki T, Morikawa N, Okitsu O, Nishimura S, Aoki T, Katayama Y, Kita Y 2005 Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor. J Neurochem 94:1264-1276
44. Zhu Y, Lee HC, Zhang L 2002 An examination of heme action in gene expression: heme and heme deficiency affect the expression of diverse genes in erythroid k562 and neuronal PC12 cells. DNA Cell Biol 21:333-346
45. Lee KH, Ryu CJ, Hong HJ, Kim J, Lee EH 2005 CDNA microarray analysis of nerve growth factor-regulated gene expression profile in rat PC12 cells. Neurochem Res 30:533-540
46. Marek L, Levresse V, Amura C, Zentrich E, Van Putten V, Nemenoff RA, Heasley LE 2004 Multiple signaling conduits regulate global differentiation- specific gene expression in PC12 cells. J Cell Physiol 201:459-469
47. Lee NH, Weinstock KG, Kirkness EF, Earle-Hughes JA, Fuldner RA, Marmaros S, Glodek A, Gocayne JD, Adams MD, Kerlavage AR, Fraser CM, Venter JC 1995 Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proc Natl Acad Sci USA 92:8303-8307
48. Vician L, Basconcillo R, Herschman HR 1997 Identification of genes preferentially induced by nerve growth factor versus epidermal growth factor in PC12 pheochromocytoma cells by means of representational difference analysis. J Neurosci Res 50:32-43
49. Brown AJ, Hutchings C, Burke JF, Mayne LV 1999 Application of a rapid method (targeted display) for the identification of differentially expressed mRNAs following NGF-induced neuronal differentiation in PC12 cells. Mol Cell Neurosci 13:119-130
50. Chou TT, Trojanowski JQ, Lee VM 2001 p38 mitogen-activated protein kinase-independent induction of gadd45 expression in nerve growth factor-induced apoptosis in medulloblastomas. J Biol Chem 276:41120-41127
51. Vician L, Silver AL, Farias-Eisner R, Herschman HR 2001 NID67, a small putative membrane protein, is preferentially induced by NGF in PC12 pheochromocytoma cells. J Neurosci Res 64:108-120
52. Imaizumi K, Tsuda M, Imai Y, Wanaka A, Takagi T, Tohyama M 1997 Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. J Biol Chem 272:18842-18848
53. Maher P 2006 Redox control of neural function: background, mechanisms, and significance. Antioxid Redox Signal 8:1941-1970
54. Noble M, Mayer-Proschel M, Proschel C 2005 Redox regulation of precursor cell function: insights and paradoxes. Antioxid Redox Signal 7:1456-1467
55. Chesler M 2003 Regulation and modulation of pH in the brain. Physiol Rev 83:1183-1221
56. Dickens CJ, Gillespie JI, Greenwell JR 1989 Interactions between intracellular pH and calcium in single mouse neuroblastoma (N2A) and rat pheochromocytoma cells (PC12). Q J Exp Physiol 74:671-679
57. Zhang KZ, Westberg JA, Paetau A, von Boguslawsky K, Lindsberg P, Erlander M, Guo H, Su J, Olsen HS, Andersson LC 1998 High expression of stanniocalcin in differentiated brain neurons. Am J Pathol 153:439-445
58. Wong CK, Yeung HY, Mak NK, DiMattia GE, Chan DK, Wagner GF 2002 Effects of dibutyryl cAMP on stanniocalcin and stanniocalcin-related protein mRNA expression in neuroblastoma cells. J Endocrinol 173:199-209
59. Westberg JA, Serlachius M, Lankila P, Penkowa M, Hidalgo J, Andersson LC 2007 Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 38:1025-1030
60. Ehrhart J, Gluck M, Mieyal J, Zeevalk GD 2002 Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism Relat Disord 8:395-400
61. Watanabe E, Fujikawa A, Matsunaga H, Yasoshima Y, Sako N, Yamamoto T, Saegusa C, Noda M 2000 Nav2/NaG channel is involved in control of salt-intake behavior in the CNS. J Neurosci 20:7743-7751
62. Kujubu DA, Lim RW, Varnum BC, Herschman HR 1987 Induction of transiently expressed genes in PC-12 pheochromocytoma cells. Oncogene 1:257-262
63. Federoff HJ, Grabczyk E, Fishman MC 1988 Dual regulation of GAP-43 gene expression by nerve growth factor and glucocorticoids. J Biol Chem 263:19290-19295
64. Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA 2001 Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem 276:49350-49358
65. Hajjar KA, Jacovina AT, Chacko J 1994 An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269:21191-21197
66. Cesarman GM, Guevara CA, Hajjar KA 1994 An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 269:21198-21203
67. Luo W, Wickramasinghe SR, Savitt JM, Griffin JW, Dawson TM, Ginty DD 2007 A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons. Neuron 54:739-754
68. Hayden SM, Seeds NW 1996 Modulated expression of plasminogen activator system components in cultured cells from dissociated mouse dorsal root ganglia. J Neurosci 16:2307-2317
69. Siconolfi LB, Seeds NW 2001 Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J Neurosci 21:4348-4355
70. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, Levitt P 2003 Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 23:622-631
71. Levitt P 2005 Disruption of interneuron development. Epilepsia 46 (Suppl. 7):22-28
72. Machida CM, Rodland KD, Matrisian L, Magun BE, Ciment G 1989 NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells. Neuron 2:1587-1596
73. Seeds NW, Siconolfi LB, Haffke SP 1997 Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding. Cell Tissue Res 290:367-370
74. Muir D 1994 Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 210:243-252
75. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR 1997 Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 272:28563-28567
76. Nguyen JT, Turck CW, Cohen FE, Zuckermann RN, Lim WA 1998 Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science 282:2088-2092
77. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F 1996 Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 15:1572-1582
78. Busso N, Masur SK, Lazega D, Waxman S, Ossowski L 1994 Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 126:259-270
79. Del Rosso M, Anichini E, Pedersen N, Blasi F, Fibbi G, Pucci M, Ruggiero M 1993 Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 190:347-352
80. Anichini E, Zamperini A, Chevanne M, Caldini R, Pucci M, Fibbi G, Del Rosso M 1997 Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters. Biochem 36:3076-3083
81. Goretzki L, Mueller BM 1997 Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMP-dependent protein kinase. J Cell Sci 110(Pt 12):1395-1402
82. Cao D, Mizukami IF, Garni-Wagner BA, Kindzelskii AL, Todd III RF, Boxer LA, Petty HR 1995 Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol 154:1817-1829
83. Vilhardt F, Nielsen M, Sandvig K, van Deurs B 1999 Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells. Mol Biol Cell 10:179-195
84. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA 1999 A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 144:1285-1294
85. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA 1996 Regulation of integrin function by the urokinase receptor. Science 273:1551-1555
86. McFarlane S 2003 Metalloproteases: carving out a role in axon guidance. Neuron 37:559-562
87. VanSaun MN, Matrisian LM 2006 Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res C Embryo Today 78:69-79
88. Wetzel M, Rosenberg GA, Cunningham LA 2003 Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 18:1050-1060
89. Su F, Kozak KR, Herschman H, Reddy ST, Farias-Eisner R 2007 Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells. J Neurosci Res 85:1952-1958
90. Zhang Y, Zhu W, Wang YG, Liu XJ, Jiao L, Liu X, Zhang ZH, Lu CL, He C 2006 Interaction of SH2-Bβ with RET is involved in signaling of GDNF-induced neurite outgrowth. J Cell Sci 119:1666-1676
91. Duan C, Li M, Rui L 2004 SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J Biol Chem 279:43684-43691
92. Rabbani SA, Gladu J 2002 Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo. Cancer Res 62:2390-2397
93. Kendziorski CM, Zhang Y, Lan H, Attie AD 2003 The efficiency of pooling mRNA in microarray experiments. Biostatistics 4:465-477
94. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN 2005 On the utility of pooling biological samples in microarray experiments. Proc Nat Acad Sci USA 102:4252-4257